China’s Lepu Biopharma and DP Technology Achieve Breakthrough in ADC Cancer Drug Development

This partnership has effectively integrated DP's ADC Linker-Payload design platform with Lepu's ADC technology development platform, capitalizing on...

November 21, 2024 | Thursday | News
Abzena Expands Analytical Capabilities with GMP Cell-Based Potency Assays at Cambridge and San Diego Facilities

" Abzena, a leading CDMO/CRO, now offers GMP cell-based potency assays at its UK and US sites, enhancing its support for complex biologics and ADC programs...

November 20, 2024 | Wednesday | News
TAE Life Sciences and Stella Pharma Announce Exclusive Collaboration to Expand BNCT Therapy in the U.S. and Europe

TAE Life Sciences (TLS), a leader in boron neutron capture therapy (BNCT) technology, and Stella Pharma, the pioneering developer of the boronophenylalan...

November 14, 2024 | Thursday | News
IDEAYA Secures Global Rights to Biocytogen’s Innovative BsADC Candidate, IDE034

IDEAYA Secures Exclusive Global License for Biocytogen’s First-In-Class BsADC, B7H3/PTK7 Topo-I Payload (IDE034), Validating Biocytogen’s Ren...

November 12, 2024 | Tuesday | News
Alteogen and Daiichi Sankyo Partner to Develop Subcutaneous ENHERTU® Using Novel Hyaluronidase Technology

Alteogen Inc. (KOSDAQ:196170) announced that the company has entered into an exclusive license agreement with Daiichi Sankyo (TSE: 4568). Under the terms o...

November 11, 2024 | Monday | News
Ionis Pharmaceuticals Announces Phase 3 Study Design for ION582 in Angelman Syndrome Following FDA Alignment

 Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced the pivotal Phase 3 study design following successful alignment with the U.S. Food and...

November 07, 2024 | Thursday | News
Ring Therapeutics Strengthens Partnerships with Singapore’s A*STAR and SERI to Advance Gene Therapy for Eye Diseases and Cancer

Ring Therapeutics, a pioneering life sciences company under Flagship Pioneering dedicated to reshaping gene therapy through its unique commensal virome p...

November 05, 2024 | Tuesday | News
Complete Genomics Showcases Expanded Applications and Innovations for DNBSEQ-T7 at ASHG 2024

At the American Society of Human Genetics (ASHG) Annual Meeting (Nov. 5-9, 2024), Complete Genomics, a pioneering genomic sequencing company, will highligh...

November 05, 2024 | Tuesday | News
Theriva Biologics Named Finalist for Merck KGaA’s EMEA Advance Biotech Grant

Theriva™ Biologics (NYSE American: TOVX), a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer and relate...

November 04, 2024 | Monday | News
Genentech Publishes Positive Phase III Results for Itovebi in Advanced Breast Cancer in NEJM

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that a detailed analysis of the positive Phase III INAVO120 results, evaluat...

November 01, 2024 | Friday | News
Abzena Expands Quality Control Testing Capabilities at San Diego Facility, Elevating Biologics Manufacturing and Microbiology Standards

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) test...

October 31, 2024 | Thursday | News
Jubilant Therapeutics Advances Innovative Cancer Therapies with First Patient Dosing in Global Trials for JBI-802 and JBI-778

JBI-802 is a first-in-class, orally administered, inhibitor of CoREST complex JBI-778 is a potential best-in-class, orally ad...

October 28, 2024 | Monday | News
RiboX Therapeutics Secures FDA Clearance for First-Ever Circular RNA Therapy RXRG001 in Phase I/IIa Study

RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics...

October 28, 2024 | Monday | News
Exact Sciences to Present Innovative CRC Screening Data at ACG Annual Meeting

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced the company will present modeling data evaluati...

October 28, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close